Maple Capital Management, Inc. Tyme Technologies, Inc. Transaction History

Maple Capital Management, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 17, 2022	SELL	$0.28 - $0.68 $2,800 - $6,800	-10,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$0.9 - $1.95 $9,000 - $19,500	10,000 New	10,000 $11,000

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

Get notified when there are updates to the investment portfolio of Maple Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Maple Capital Management, Inc. with notifications on news.